Articles for BTG (LSE: BTG)

Can this FTSE 250 pharma winner crush the AstraZeneca share price in 2019?

AstraZeneca plc (LON: AZN) shares are climbing, but here's a pharma stock that could beat them in 2019. More »

Why this FTSE 250 stock plus 5%-yielder Royal Mail could help you retire early

Rupert Hargreaves confirms FTSE 250 (INDEXFTSE:MCX) growth stock BTG plc (LON: BTG) and Royal Mail plc (LON:RMG) for his buy list. More »

2 Footsie 250 stocks I’m avoiding at all costs

Rupert Hargreaves looks at why these two FTSE 250 (INDEXFTSE: MCX) investments could be a threat to your wealth. More »

Why I’d buy FTSE 100 stock Smurfit Kappa Group plc before BTG plc today

I think the growth story at BTG plc (LON: BTG) looks stale while Smurfit Kappa Group plc (LON:SKG) shines. More »

Two growth stocks I’d buy for my ISA today

These two shares appear to have significant long-term growth potential which may boost their share price performance. More »

Why I’d buy Neil Woodford favourite Provident Financial plc today

Neil Woodford has invested serious money in Provident Financial plc (LON: PFG), and Alan Oscroft would too. More »

One Neil Woodford growth stock I’d buy, and one I’d sell

These two Neil Woodford growth stocks could deliver contrasting returns for investors in 2018, says G A Chester. More »

2 pharma stocks that could make you a millionaire

The FTSE 100 isn’t the last word for great pharmaceutical stocks. Here, Royston Wild looks at two medical marvels outside of the blue-chip index. More »

A growth stock I’d buy alongside this Neil Woodford favourite

Top investor Neil Woodford has a nose for major growth stocks, and you can follow his lead. More »

2 growth stocks I’d buy and hold for 25 years

These two growth shares appear to have upside potential. More »

3 stocks Neil Woodford should buy more of

I believe that these three Neil Woodford stocks look undervalued. More »

2 undervalued mid-caps that could help you retire early

These two stocks have stunning potential, says G A Chester. More »

I’d ditch ReNeuron Group plc to buy another Neil Woodford favourite

This profitable growth company could serve you better than gambling with ReNeuron Group plc (LON: RENE). More »

These 2 FTSE 250 turnaround stocks are both up 20% in six months

The FTSE 250 (INDEXFTSE:MCX) is full of hidden gems like these two growers, says Harvey Jones. More »

2 super growth stocks I’d buy now

These two shares could be on the cusp of improved share price performance. More »

Why this growth stock could double by 2019

Bilaal Mohamed reckons this pharmaceutical stock could double within the next couple of years. More »

Two FTSE 250 growth stocks I’d buy before it’s too late

These two FTSE 250 (INDEXFTSE:MCX) companies could be worth buying right now. More »

2 beaten-down growth bargains set to rebound

Why I think these two stocks could return to former glories and more. More »

2 ‘hot’ growth shares I’d buy in January

Bilaal Mohamed explains why January could be a good time to buy these exciting growth stocks. More »

3 growth shares to buy for 2017

Are these three of the best growth bargains for the year ahead? More »